Validation studies performed by the same group indicated a correlation between staining intensity for PAFAH and Gleason Score in 50 % of the cases, thus suggesting that both enzymes can be seen as biomarkers for PCa, and the PAFAH inhibition by statins as a therapeutic tool for managing the disease [29]. Here, PLA2G7 is linked to posterior cortical atrophy.